Jill Hallin

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

March, 2025

Jill Hallin

Dec 29, 2024, 11:07 | Science

The highest cited original research publications in Pancreatic Cancer from 2020 to 2024 by Anirban Maitra

Anirban Maitra, Professor of Pathology and Translational Molecular Pathology at UT MD Anderson Cancer Center,…

Dec 25, 2024, 18:18 | Blog

A classical epithelial cancer cell state drives resistance to KRAS inhibition in Pancreatic Cancer - NCI Division of Cancer Biology

NCI Division of Cancer Biology shared a post on X: “Using reporter systems and preclinical…

Jul 10, 2024, 07:19 | Insight

Tuomas Tammela: Co-targeting classical cells and KRAS augments response in pancreas cancer

Tuomas Tammela, Associate Member at Memorial Sloan Kettering Cancer Center, shared on X: "New Paper!…

All: 3 Posts: 1 - 100

'

Karen Knudsen has been appointed as the CEO of the Parker Institute for Cancer Immunotherapy

'

Highlights from ELCC 2025

'

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023